Biogen (NASDAQ: BIIB) faces continued challenges for several of its current products. In this Motley Fool Live video, recorded on July 19, 2021, healthcare and cannabis bureau chief Corinne Cardina and Motley Fool contributor Keith Speights answer a viewer's question about whether now is a good time to buy Biogen stock. Corinne Cardina: This person, Fan of Brian and Brian but not Brian, I believe they are trying to stir the pot in terms of all of our Brians.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting